IM Ingram Micro Inc. (delisted)

• Rights offering important next step in financial restructuring of Royal Imtech
• Offering of 356,597,988 new ordinary shares at an issue price of EUR 1.40 per new ordinary share
• Issue price represents a discount of approximately 37.3% to the theoretical ex-rights price
• Fully underwritten by ING, Rabobank and Commerzbank, subject to customary conditions
• ING AM has committed to participate in the rights offering
• Record date on 4 July 2013 at 17:40 CEST
• Exercise period from 5 July 2013 9:00 CEST to 18 July 2013 17:00 CEST
• Rump offering (if any) expected on 19 July 2013
• ING and Rabobank acting as Joint Global Coordinators and Joint Bookrunners; Commerzbank acting as Co-Lead Manager

Gerard van de Aast, CEO Royal Imtech: "Today's launch of the fully underwritten rights offering is an important step in our recovery plan. Our shareholders approved the rights issue with 98.6% of the votes cast and can now participate in this important rights offering at terms in line with similar precedent transactions in the market. The net proceeds of the rights offering will be used to reduce the net debt level of our company. From now on, we must look forward and continue with our recovery plan. Our core value proposition based on our technological capabilities and market coverage is still intact. The people at Royal Imtech will move forward and continue to make serving their customers their top priority."

Following the approval granted by the General Meeting on 28 June 2013, Royal Imtech N.V. ("Royal Imtech" or the "Company") announces a 4 for 1 fully underwritten rights offering of 356,597,988 new ordinary shares with a nominal value of EUR 0.80 each in its share capital (the "Offer Shares") at an issue price of EUR 1.40 per Offer Share (the "Issue Price"). For this purpose, subject to applicable securities laws and the terms of the prospectus dated 4 July 2013 (the "Prospectus"), existing holders of ordinary shares in the share capital of Royal Imtech ("Ordinary Shares") as at 4 July 2013 at 17:40 CEST (the "Record Date") are being granted transferable subscription rights ("Rights") pro rata to their existing shareholdings (the "Rights Offering", and together with the Rump Offering (as defined below) the "Offering"). No Rights will be granted to Royal Imtech as a holder of Ordinary Shares in its own capital. The Rights will entitle the holders thereof, provided they are Eligible Persons, to subscribe for 4 Offer Shares for every Right held at the Issue Price, subject to applicable securities laws and in accordance with the terms and subject to the conditions set out in the Prospectus. The Issue Price per Offer Share represents a discount of approximately 37.3% to the theoretical ex-rights price ("TERP") based on the share price of EUR 5.570 at NYSE Euronext in Amsterdam ("Euronext Amsterdam") after close of business on 3 July 2013 and 89,149,497 shares issued and outstanding at the same date (thus excluding treasury shares).

ING AM Insurance Companies B.V. ("ING AM") has irrevocably committed to participate in the Rights Offering by timely and duly exercising all of the Rights that it shall receive, thereby subscribing for all Offer Shares offered to it pro rata its capital interest in Royal Imtech, resulting in a total pre-commitment of 5.72% of the Offer Shares (the "Committed Shares").

ING and Rabobank are acting as joint global coordinators and joint bookrunners for the Offering (the "Joint Global Coordinators" or the "Joint Bookrunners"), and Commerzbank is acting as co-lead manager for the Offering (the "Co-Lead Manager", and together with the Joint Bookrunners, the "Managers"). The Managers have, subject to customary conditions including the condition that ING AM subscribes for the Committed Shares, underwritten the Offering. ING Bank N.V. will act as subscription, listing and paying agent (the "Subscription, Listing and Paying Agent") for the Offering.

In connection with the Offering the Prospectus will be made generally available in The Netherlands. Copies of the Prospectus may be obtained at no cost through the website of Royal Imtech (www.imtech.com) as of today. Application has been made for the admission to listing and trading of the Rights and the Offer Shares on Euronext Amsterdam.

The net proceeds of the Offering will be fully utilised for debt reduction, resulting in a reinforcement of Royal Imtech's capital structure.

Detailed terms of the Offering are set out in the Prospectus, which is expected to be available as of today.

Royal Imtech and the Managers are not taking any action to register the Rights or the Offer Shares or otherwise to permit an offering of the Offer Shares (pursuant to the exercise of Rights or otherwise), or an offer of Rights in any jurisdiction outside of the Netherlands. The Offering is only made in those jurisdictions in which, and only to those persons to whom, the Offering may lawfully be made. Holders of Ordinary Shares as of the Record Date and subsequent transferees of the Rights, in each case if they are able to give the representations and warranties set out in the Prospectus, are considered eligible persons ("Eligible Persons") with respect to the Offering.

The statutory pre-emptive rights (wettelijke voorkeursrechten) of holders of Ordinary Shares have been excluded with respect to the Offering.

Each Ordinary Share held immediately after the close of trading on Euronext Amsterdam on the Record Date will entitle its holder to one Right in registered form. Eligible Persons will have the right, until the end of the Exercise Period, to subscribe for 4 Offer Shares for every Right held. No fractional Offer Shares will be issued. No Rights will be granted to Royal Imtech as a holder of Ordinary Shares in its own capital. A holder of Ordinary Shares as at the Record Date will customarily receive details of the aggregate number of Rights to which he will be entitled from the financial intermediary through which he holds his Ordinary Shares. Shareholders should contact the financial intermediary through which they hold the Ordinary Shares if they are entitled to receive Rights but have received no information from their financial intermediary with respect to the Rights Offering.

Subject to applicable securities laws and the terms set out in the Prospectus, Eligible Persons (whether a holder of Ordinary Shares on the Record Date or a subsequent transferee of Rights) will be entitled to subscribe for 4 Offer Shares for every Right held against payment of the Issue Price for each Offer Share by exercising their Rights during the period running from 9:00 CEST on 5 July 2013 and ending at 17:00 CEST on 18 July 2013 (the "Exercise Period"). Subject to applicable securities laws, Eligible Persons can only validly exercise their Rights during the Exercise Period. The time until which notification of exercise instructions must be given in order to be valid may be earlier, depending on the financial institution through which the Rights are held. Once an Eligible Person holding Rights has exercised its Rights, it may not revoke or modify that exercise, except as otherwise described in the Prospectus. If an Eligible Person holding Rights has not timely or validly exercised its Rights before the end of the Exercise Period (or so much earlier as instructed by its financial intermediary), it will no longer be able to exercise its Rights and its Rights will lapse. Holders of Ordinary Shares who transfer, or who do not, not timely, or are not permitted to, exercise any of their Rights granted under the Rights Offering will suffer a dilution of their proportionate ownership and voting rights caused by the issue of the Offer Shares.

Trading in Rights on Euronext Amsterdam is expected to commence at 9:00 CEST on 5 July 2013 and will continue until 15:00 CEST on 18 July 2013, barring unforeseen circumstances. The Rights will be admitted to trading under the symbol "IMR". The transfer of Rights will take place through the book-entry systems of Euroclear Nederland. If Eligible Persons want to sell some or all of their Rights, they should instruct their financial intermediary in accordance with the instructions given by the intermediary to them. Eligible Persons may also instruct their financial intermediary to purchase Rights on their behalf. Persons interested in trading, selling or purchasing Rights should be aware that the trading or exercise of Rights and/or acquiring Offer Shares by holders residing in countries other than the Netherlands, is subject to restrictions as set out in the Prospectus and such holders may therefore be ineligible to participate in the Rights Offering. Any failure to comply with these restrictions may constitute a violation of the securities laws or regulations (or other laws or regulations) of any such countries.

Rights can no longer be exercised after 17:00 CEST on 18 July 2013, at which time the Exercise Period ends (or so much earlier as indicated by the relevant financial intermediary). Following the expiry of the Exercise Period, any Offer Shares that were issuable upon the exercise of Rights, but have not been subscribed for or that have been subscribed but not paid for in full during the Exercise Period (the "Rump Shares"), may in accordance with the provisions of the Underwriting Agreement (as defined below) be offered for sale by the Joint Bookrunners by way of private placements to institutional investors in the Netherlands and certain other jurisdictions (the "Rump Offering") at a price at least equal to the Issue Price. If there is a Rump Offering, it is expected to commence on 19 July 2013 at 7:30 CEST and to end no later than 17:30 CEST on that same day.

The Managers, severally and not jointly, will subscribe and pay for (i) any Offer Shares subscribed for in the Rights Offering but not paid for by such subscribers on the Settlement Date (as defined below), and (ii) any Rump Shares not sold in the Rump Offering, if any, or sold but not paid for on the Closing Date (as defined below), pro rata to their respective underwriting commitments at the Issue Price, in accordance with the terms and subject to the conditions of the underwriting agreement entered into between the Managers and Royal Imtech (the "Underwriting Agreement").

Upon completion of the Rump Offering, if the aggregate proceeds for each Rump Share offered and sold in the Rump Offering, after deduction of selling expenses (including any value added tax), exceed the aggregate issue price for such Rump Shares (such amount, the "Excess Amount"), each holder of a Right that was not exercised at the end of the Exercise Period will be entitled to receive, except as noted below, a part of the Excess Amount.

Such holder will be entitled to receive such part of the Excess Amount in cash pro rata to the number of unexercised Rights reflected in such holder's securities account (the "Unexercised Rights Payment"), but only if that amount exceeds EUR 0.01 per unexercised Right. Royal Imtech will announce whether any Unexercised Rights Payment is available for distribution to holders of unexercised Rights by means of a press release. Royal Imtech and the Joint Bookrunners cannot guarantee that the Rump Offering, if any, will be successfully completed. Royal Imtech, the Managers, the Subscription, Listing and Paying Agent or any person procuring subscriptions for Rump Shares will not be responsible for any lack of Excess Amount arising from any placement of the Rump Shares whether or not a Rump Offering takes place.

The timetable below lists certain expected key dates related to the Offering.

Royal Imtech may adjust the dates, times and periods given in the timetable and throughout the Prospectus. If Royal Imtech should decide to adjust dates, times or periods, it will notify Euronext Amsterdam and the Authority for the Financial Markets (Autoriteit Financiële Markten) ("AFM") and it will publish a press release in the Netherlands which will also be placed on its website www.imtech.com. Any other material alterations will be published in a press release also posted on Royal Imtech's website and in a supplement to the Prospectus (if required).

The closing of the Offering, including the obligations of the Managers under the Underwriting Agreement, is subject to customary terms and conditional upon the fulfilment of a number of conditions precedent as set out in the Prospectus under "Plan of Distribution".

For more information on the Offering and Royal Imtech, reference is made to the Prospectus dated 4 July 2013. Copies of this Prospectus and any supplement to this Prospectus (if any) can be accessed via the website of Royal Imtech at www.imtech.com.

For more information, shareholders can also contact their broker or the shareholders help line at the following European toll-free number: 00800 3814 3814 or send an email to imtech@georgeson.com.

Royal Imtech is a European technical services provider in the fields of electrical solutions, ICT (information and communication technology) and mechanical solutions. With 29,000 employees, Royal Imtech achieves annual revenue of approximately 5.4 billion euro. Royal Imtech holds attractive positions in the buildings and industry markets in the Netherlands, Belgium, Luxembourg, Germany, Austria, Eastern Europe, Sweden, Norway, Finland, the UK, Ireland, Turkey and Spain, the European markets of ICT and Traffic as well as in the global marine market. In total Royal Imtech serves 24,000 customers. Royal Imtech offers integrated and multidisciplinary total solutions that lead to better business processes and more efficiency for customers and the customers they, in their turn, serve. Royal Imtech also offers solutions that contribute towards a sustainable society - for example, in the areas of energy, the environment, water and traffic. Royal Imtech shares are listed on the NYSE Euronext Amsterdam, where Royal Imtech is included in the AEX Index.

This press release is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, into or in the United States, Australia, Canada or Japan or any (other) jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

This press release is for information purposes only and is not intended to constitute, and should not be construed as, an offer to sell or a solicitation of any offer to buy securities of Royal Imtech N.V. (the "Company", and such securities, the "Securities") in the United States, Australia, Canada or Japan or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of such jurisdiction.

The Securities have not and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") and will not be registered with any authority competent with respect to securities in any state or other jurisdiction of the United States of America. The Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the U.S. Securities Act. The Company has registered no part of the offering of the Securities in the United States of America or any other jurisdiction, nor has it the intention to do so. The Company has no intention to make a public offering of Securities in the United States.

The Company has not authorised any offer to the public of Securities in any Member State of the European Economic Area (except that it may do so in respect of the Netherlands). With respect to any Member State of the European Economic Area (other than possibly the Netherlands), and which has implemented the Prospectus Directive (each a "Relevant Member State"), no action has been undertaken or will be undertaken to make an offer to the public of Securities requiring publication of a prospectus in any Relevant Member State. As a result, the Securities may only be offered in Relevant Member States (i) to any legal entity which is a qualified investor as defined in the Prospectus Directive; or (ii) in any other circumstances falling within Article 3(2) of the Prospectus Directive. For the purpose of this paragraph, the expression "offer of securities to the public" means the communication in any form and by any means of sufficient information on the terms of the offer and the Securities to be offered so as to enable the investor to decide to exercise, purchase or subscribe for the securities, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State and the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State.

The release, publication or distribution of this press release in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions.

This press release does not constitute a prospectus within the meaning of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht) and does not constitute an offer to acquire securities.

Any offer to acquire Securities pursuant to the proposed offering will be made, and any investor should make his investment, solely on the basis of information that will be contained in the prospectus made generally available in the Netherlands in connection with such offering. Copies of the prospectus may be obtained at no cost from the Company or through the website of the Company.

Ingram Micro A (NYSE:IM)
Historical Stock Chart
From Jul 2024 to Aug 2024

Ingram Micro A (NYSE:IM)
Historical Stock Chart
From Aug 2023 to Aug 2024